ETF constituents for IBRN

Below, a list of constituents for IBRN (iShares Neuroscience and Healthcare ETF) is shown. In total, IBRN consists of 56 securities.

Note: The data shown here is as of date - (the latest that can be sourced directly from the fund provider).

Click here to go back to the full list of ETFs.

Ticker Name Sector Asset Class Market Value Weight (%)
ITCI INTRA CELLULAR THERAPIES INC Health Care Equity 244714.3 5.19
PTCT PTC THERAPEUTICS INC Health Care Equity 212296.7 4.5
ALKS ALKERMES Health Care Equity 204504.82 4.34
BIIB BIOGEN INC Health Care Equity 203871.33 4.32
IART INTEGRA LIFESCIENCES HOLDINGS CORP Health Care Equity 202737.24 4.3
NBIX NEUROCRINE BIOSCIENCES INC Health Care Equity 196435.8 4.16
XENE XENON PHARMACEUTICALS INC Health Care Equity 192721.32 4.09
AXNX AXONICS INC Health Care Equity 189836.49 4.02
CPRX CATALYST PHARMACEUTICALS INC Health Care Equity 188615.14 4.0
KRTX KARUNA THERAPEUTICS INC Health Care Equity 184705.0 3.92
ACAD ACADIA PHARMACEUTICALS INC Health Care Equity 184120.2 3.9
SUPN SUPERNUS PHARMACEUTICALS INC Health Care Equity 182546.91 3.87
PRTA PROTHENA PLC Health Care Equity 176675.62 3.75
SRPT SAREPTA THERAPEUTICS INC Health Care Equity 175070.61 3.71
CERE CEREVEL THERAPEUTICS HOLDINGS INC Health Care Equity 172584.0 3.66
326030 SK BIOPHARMACEUTICALS LTD Health Care Equity 157550.4 3.34
IDIA IDORSIA N LTD Health Care Equity 154258.69 3.27
NVRO NEVRO CORP Health Care Equity 139964.74 2.97
AMLX AMYLYX PHARMACEUTICALS INC Health Care Equity 135723.58 2.88
HRMY HARMONY BIOSCIENCES HLDG INC Health Care Equity 126635.0 2.68
NEU NEUREN PHARMACEUTICALS LTD Health Care Equity 112413.89 2.38
SAVA CASSAVA SCIENCES INC Health Care Equity 107732.87 2.28
BIOA B BIOARCTIC CLASS B Health Care Equity 106936.15 2.27
BHVN BIOHAVEN LTD Health Care Equity 92285.28 1.96
AVXL ANAVEX LIFE SCIENCES CORP Health Care Equity 73307.52 1.55
9996 PEIJIA MEDICAL LTD Health Care Equity 63929.48 1.36
AVDL AVADEL PHARMACEUTICALS ADR PLC Health Care Equity 55584.48 1.18
ALEC ALECTOR INC Health Care Equity 43940.16 0.93
AXGN AXOGEN INC Health Care Equity 43667.13 0.93
VNDA VANDA PHARMACEUTICALS INC Health Care Equity 42970.84 0.91
BTAI BIOXCEL THERAPEUTICS INC Health Care Equity 41775.6 0.89
DYN DYNE THERAPEUTICS INC Health Care Equity 40680.54 0.86
MRNS MARINUS PHARMACEUTICALS INC Health Care Equity 37564.26 0.8
EWTX EDGEWISE THERAPEUTICS INC Health Care Equity 31768.2 0.67
WVE WAVE LIFE SCIENCES LTD Health Care Equity 28633.29 0.61
PEPG PEPGEN LTD Health Care Equity 26646.84 0.56
VYGR VOYAGER THERAPEUTICS INC Health Care Equity 22557.84 0.48
DSGN DESIGN THERAPEUTICS INC Health Care Equity 21813.9 0.46
XERS XERIS BIOPHARMA HOLDINGS INC Health Care Equity 21504.34 0.46
ZVRA ZEVRA THERAPEUTICS INC Health Care Equity 20234.17 0.43
268600 CELLIVERY THERAPEUTICS INC Health Care Equity 18330.6 0.39
ANNX ANNEXON INC Health Care Equity 13451.9 0.29
ATHA ATHIRA PHARMA INC Health Care Equity 10779.72 0.23
STIM NEURONETICS INC Health Care Equity 8424.45 0.18
USD USD CASH Cash and/or Derivatives Cash 1887.64 0.04
KRW KRW CASH Cash and/or Derivatives Cash 779.55 0.02
EUR EUR CASH Cash and/or Derivatives Cash 547.84 0.01
HKD HKD CASH Cash and/or Derivatives Cash 474.38 0.01
DKK DKK CASH Cash and/or Derivatives Cash 446.6 0.01
SEK SEK CASH Cash and/or Derivatives Cash 253.83 0.01
AUD AUD CASH Cash and/or Derivatives Cash 198.76 0.0
CHF CHF CASH Cash and/or Derivatives Cash 150.0 0.0
EUR EUR/USD Cash and/or Derivatives FX -0.13 0.0
HKD HKD/USD Cash and/or Derivatives FX 0.03 0.0
DKK DKK/USD Cash and/or Derivatives FX -0.31 0.0
The content contained herein is owned or licensed by BlackRock and/or its third-party information providers and is protected by applicable copyrights, trademarks, service marks, and/or other intellectual property rights. Such content is solely for your personal, non-commercial use. Accordingly, you may not copy, distribute, modify, post, frame or deep link this content. You may download material displayed on this Website for your personal use provided you also retain all copyright and other proprietary notices contained on the materials. Modification or use of the materials for any other purpose violates BlackRock's intellectual property rights. Holdings subject to change. See www.iShares.com for the most recent funds holdings. The values for “price” shown herein generally represent a price provided by a third-party pricing vendor for the portfolio holding and do not reflect the impact of systematic fair valuation (“the vendor price”). The vendor price is not necessarily the price at which the Fund values the portfolio holding for the purposes of determining its net asset value (the “valuation price”). Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U.S. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p.m. London. The values shown herein for “market value,” “weight,” and “notional value” (the “calculated values”) are based off of the vendor price and may have been different if the valuation price were to have been used to calculate such values. The vendor price is as of the most recent practicable date and may not necessarily be as of the date shown above. Please see the “Determination of Net Asset Value” section of each Fund’s prospectus for additional information on the Fund’s valuation policies and procedures. CAREFULLY CONSIDER THE FUNDS' INVESTMENT OBJECTIVES, RISK FACTORS, AND CHARGES AND EXPENSES BEFORE INVESTING. THIS AND OTHER INFORMATION CAN BE FOUND IN THE FUNDS' PROSPECTUSES OR, IF AVAILABLE, THE SUMMARY PROSPECTUSES WHICH MAY BE OBTAINED BY VISITING WWW.ISHARES.COM OR WWW.BLACKROCK.COM. READ THE PROSPECTUS CAREFULLY VEFORE INVESTING. INVESTING INVOLVES RISK, INCLUDING POSSIBLE LOSS OF PRINCIPAL. This information should not be relied upon as research, investment advice, or a recommendation regarding any products, strategies, or any security in particular. This material is strictly for illustrative, educational, or informational purposes and is subject to change. The iShares Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”). The iShares Funds are not sponsored, endorsed, issued, sold or promoted by Barclays, Bloomberg Finance L.P., BlackRock Index Services, LLC, Cohen & Steers Capital Management, Inc., European Public Real Estate Association (“EPRA® ”), FTSE International Limited (“FTSE”), ICE Data Services, LLC, India Index Services & Products Limited, JPMorgan Chase & Co., Japan Exchange Group, MSCI Inc., Markit Indices Limited, Morningstar, Inc., The NASDAQ OMX Group, Inc., National Association of Real Estate Investment Trusts (“NAREIT”), New York Stock Exchange, Inc., Russell or S&P Dow Jones Indices LLC. None of these companies make any representation regarding the advisability of investing in the Funds. With the exception of BlackRock Index Services, LLC, who is an affiliate, BlackRock Investments, LLC is not affiliated with the companies listed above. Neither FTSE nor NAREIT makes any warranty regarding the FTSE NAREIT Equity REITS Index, FTSE NAREIT All Residential Capped Index or FTSE NAREIT All Mortgage Capped Index; all rights vest in NAREIT. Neither FTSE nor NAREIT makes any warranty regarding the FTSE EPRA/NAREIT Developed Real Estate ex-U.S. Index, FTSE EPRA/NAREIT Developed Europe Index or FTSE EPRA/NAREIT Global REIT Index; all rights vest in FTSE, NAREIT and EPRA.“FTSE®” is a trademark of London Stock Exchange Group companies and is used by FTSE under license. ©2021 BlackRock, Inc. All rights reserved. iSHARES and BLACKROCK are registered trademarks of BlackRock, Inc., or its subsidiaries. All other marks are the property of their respective owners. ICRMH0421U/S-1620308 nan nan nan nan nan